<DOC>
	<DOCNO>NCT00893178</DOCNO>
	<brief_summary>Pulmonary Hypertension ( PH ) disease characterize vasoconstriction small vessel lung . Many case proliferation endothelial cell within vessel . A possible influence polymorphism gene relevant inflammatory endothelial process suspect . Especially patient chronic heart failure develope PH . The reason therefore lack . The researcher investigate different polymorphism influence pulmonary artery pressure ( measure invasively ) patient congestive heart failure ( CHF ) patient primary pulmonary hypertension .</brief_summary>
	<brief_title>Impact Polymorphism Pulmonary Pressure Subjects With Pulmonary Hypertension Different Cause</brief_title>
	<detailed_description>The study consist 3 arms-patients CHF PH , patient CHF without PH patient without CHF PH . The PH measurement due routine catheterization , thereafter measure different vasoactive polymorphism .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>CHF without pulmonary hypertension patient normal LVEF pulmonary hypertension right heart catheterization due routine inform consent right heart catheterization inform consent elevate pulmonary pressure due valve disease congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>eNOS Polymorphism</keyword>
	<keyword>TNF alpha polymorphism</keyword>
	<keyword>pulmonary pressure</keyword>
	<keyword>polymorphism vasoactive substance</keyword>
</DOC>